US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SANUWAVE Health, Inc.

30.53

-2.1700-6.64%

Volume:82.97K

Turnover:2.61M

Market Cap:261.79M

PE:-28.19

High:32.49

Open:32.10

Low:30.40

Close:32.70

52wk High:46.59

52wk Low:18.50

Shares:8.58M

Float Shares:4.93M

Volume Ratio:2.18

T/O Rate:1.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0828

EPS(LYR):-7.0295

ROE:196.48%

ROA:14.91%

PB:-89.32

PE(LYR):-4.34

Loading ...

Overview Company News Filings

SANUWAVE Health Adds UltraMIST to Healogics iSupply GPO

Analysts’ Top Healthcare Picks: Rapid Micro Biosystems (RPID), Sanuwave Health (SNWV)

Sanuwave Health Inc - Q3 2025 Revenues up 22% to $11.5 Mln

THOMSON REUTERS

Sanuwave Health Inc - Q4 2025 Revenue Guidance $13-$14 Mln

THOMSON REUTERS

Sanuwave Announces Q3 FY2025 Financial Results

SANUWAVE Health Q3 EPS $0.46 Beats $0.32 Estimate, Sales $11.451M Beat $11.430M Estimate

SANUWAVE Health Inc expected to post earnings of 32 cents a share - Earnings Preview

Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

BRIEF-Sanuwave Health Says 2026 Reimbursement For 97610 Code For Ultramist Products Is Unchanged

Sanuwave Health Inc - Reimbursement for 97610 Code for Ultramist Products Remains Unchanged for 2026

THOMSON REUTERS

CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)

Opaleye Management Inc. Reports Acquisition of SANUWAVE Health Inc. Common Shares

Top Premarket Decliners

MT Newswires Live

Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)

SANUWAVE Health Inc. Files Initial Statement of Beneficial Ownership for Chief Operating Officer Daniel Coyle

Sanuwave Shares Plunge After Revenue Guidance Cut

Sanuwave Health Inc - 2025 Annual Revenue Guidance Altered to $44-$46 Mln

THOMSON REUTERS

Press Release: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)

SANUWAVE Health Appoints Daniel Coyle as COO, Terminates President Andrew Walko in Leadership Reshuffle

Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNWV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNWV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","market":"US","secType":"STK","nameCN":"SANUWAVE Health, Inc.","latestPrice":30.525,"timestamp":1765219205240,"preClose":32.695,"halted":0,"volume":82974,"delay":0,"floatShares":4925410,"shares":8576164,"eps":-1.082849,"marketStatus":"Trading","change":-2.17,"latestTime":"12-08 13:40:19 EST","open":32.1,"high":32.49,"low":30.4,"amount":2606376.964728,"amplitude":0.063924,"askPrice":30.65,"askSize":195,"bidPrice":30.4,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.082849,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765227600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":32.695,"preHourTrading":{"tag":"盘前","latestPrice":32.05,"preClose":32.695,"latestTime":"09:27 EST","volume":8417,"amount":272318.76980799995,"timestamp":1765204072165},"postHourTrading":{"tag":"盘后","latestPrice":32.695,"preClose":32.695,"latestTime":"17:01 EST","volume":442,"amount":14451.165,"timestamp":1764972091382},"volumeRatio":2.179813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","floatShares":4925410,"roa":"14.91%","roe":"196.48%","lyrEps":-7.029536,"volumeRatio":2.179813,"shares":8576164,"dividePrice":0,"high":32.49,"amplitude":0.063924,"preClose":32.695,"low":30.4,"week52Low":18.502,"pbRate":"-89.32","psRate":"6.34","week52High":46.585,"institutionHeld":0,"latestPrice":30.525,"committee":-0.979695,"eps":-1.082849,"divideRate":0,"volume":82974,"delay":0,"ttmEps":-1.082849,"open":32.1,"prevYearClose":23,"prevWeekClose":32.695,"prevMonthClose":33.92,"prevQuarterClose":37.48,"fiveDayClose":33.96,"twentyDayClose":31.08,"sixtyDayClose":36.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNWV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"SNWV","fiscalQuarterEnding":"2025/09","expectedEps":0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.46},{"date":"2025-10-06","symbol":"SNWV","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1759780800000,"name":null,"time":"Post Market","dateTimestamp":1759723200000,"actualEps":null},{"market":"US","date":"2025-08-08","symbol":"SNWV","fiscalQuarterEnding":"2025/06","expectedEps":-0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":0.01},{"date":"2025-07-14","symbol":"SNWV","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1752523200000,"name":null,"time":"Post Market","dateTimestamp":1752465600000,"actualEps":null},{"market":"US","date":"2025-05-09","symbol":"SNWV","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNWV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNWV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1756875600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNWV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNWV","date":"2025-12-05","current":-30.193499,"percent":0.095238,"low":-702.038129,"twenty":-10.143173,"median":-8.502923,"eighty":-7.743335,"high":-6.04082,"avg":-49.080863,"sd":150.510413,"marketCap":290731959},"quantilePoints":[{"date":"2025-03-07","current":-691.068781,"twenty":-691.068781,"median":-691.068781,"eighty":-691.068781,"marketCap":268825756},{"date":"2025-03-14","current":-618.012938,"twenty":-636.222054,"median":-618.342019,"eighty":-603.314015,"marketCap":240407033},{"date":"2025-03-21","current":-702.038129,"twenty":-696.553455,"median":-636.222054,"eighty":-618.012938,"marketCap":273092832},{"date":"2025-03-28","current":-10.158328,"twenty":-695.675907,"median":-618.342019,"eighty":-10.354519,"marketCap":318687073},{"date":"2025-04-04","current":-8.120123,"twenty":-691.068781,"median":-601.668614,"eighty":-10.158328,"marketCap":254744495},{"date":"2025-04-11","current":-7.981154,"twenty":-636.222054,"median":-10.315009,"eighty":-8.485256,"marketCap":250384774},{"date":"2025-04-17","current":-7.964805,"twenty":-631.834315,"median":-10.235987,"eighty":-8.284706,"marketCap":249871865},{"date":"2025-04-25","current":-8.106499,"twenty":-621.084356,"median":-9.959412,"eighty":-8.117398,"marketCap":254317071},{"date":"2025-05-02","current":-7.937556,"twenty":-618.14457,"median":-8.840852,"eighty":-7.959355,"marketCap":249017018},{"date":"2025-05-09","current":-8.596976,"twenty":-606.2538,"median":-8.485256,"eighty":-7.977884,"marketCap":269704323},{"date":"2025-05-16","current":-8.230402,"twenty":-601.997694,"median":-8.460732,"eighty":-7.977884,"marketCap":267652689},{"date":"2025-05-23","current":-7.589004,"twenty":-128.772111,"median":-8.419859,"eighty":-7.932511,"marketCap":246794415},{"date":"2025-05-30","current":-7.413815,"twenty":-10.431905,"median":-8.357187,"eighty":-7.77174,"marketCap":241097258},{"date":"2025-06-06","current":-7.313841,"twenty":-10.307106,"median":-8.265183,"eighty":-7.613389,"marketCap":237846124},{"date":"2025-06-13","current":-8.153092,"twenty":-10.259149,"median":-8.223668,"eighty":-7.613389,"marketCap":265138539},{"date":"2025-06-20","current":-8.681898,"twenty":-10.238439,"median":-8.201487,"eighty":-7.680874,"marketCap":282335328},{"date":"2025-06-27","current":-8.692422,"twenty":-10.197566,"median":-8.241733,"eighty":-7.758805,"marketCap":282677552},{"date":"2025-07-03","current":-8.32673,"twenty":-10.118545,"median":-8.276515,"eighty":-7.76153,"marketCap":270785246},{"date":"2025-07-11","current":-9.452745,"twenty":-9.895105,"median":-8.32673,"eighty":-7.767839,"marketCap":307403282},{"date":"2025-07-18","current":-9.860536,"twenty":-9.816004,"median":-8.376261,"eighty":-7.783254,"marketCap":320664627},{"date":"2025-07-25","current":-9.686619,"twenty":-9.939637,"median":-8.436208,"eighty":-7.823705,"marketCap":315008864},{"date":"2025-08-01","current":-10.137221,"twenty":-9.973066,"median":-8.489263,"eighty":-7.866852,"marketCap":329662432},{"date":"2025-08-08","current":-9.043656,"twenty":-9.939637,"median":-8.596976,"eighty":-7.885525,"marketCap":294099680},{"date":"2025-08-15","current":-8.512576,"twenty":-9.82628,"median":-8.633283,"eighty":-7.910229,"marketCap":323699228},{"date":"2025-08-22","current":-9.296689,"twenty":-9.688728,"median":-8.645066,"eighty":-7.916811,"marketCap":353515886},{"date":"2025-08-29","current":-9.562566,"twenty":-9.82628,"median":-8.68716,"eighty":-7.935294,"marketCap":363626132},{"date":"2025-09-05","current":-8.706351,"twenty":-9.689255,"median":-8.702972,"eighty":-7.937556,"marketCap":331067713},{"date":"2025-09-12","current":-8.341333,"twenty":-9.686619,"median":-8.681898,"eighty":-7.937556,"marketCap":317187545},{"date":"2025-09-19","current":-7.906466,"twenty":-9.637877,"median":-8.644164,"eighty":-7.934729,"marketCap":300651295},{"date":"2025-09-26","current":-7.847883,"twenty":-9.630162,"median":-8.596976,"eighty":-7.912332,"marketCap":298423614},{"date":"2025-10-03","current":-8.23994,"twenty":-9.612136,"median":-8.523842,"eighty":-7.909703,"marketCap":313331942},{"date":"2025-10-10","current":-7.257546,"twenty":-9.562566,"median":-8.493271,"eighty":-7.87948,"marketCap":275975441},{"date":"2025-10-17","current":-7.886188,"twenty":-9.549594,"median":-8.46215,"eighty":-7.847883,"marketCap":299880175},{"date":"2025-10-24","current":-7.068277,"twenty":-9.513256,"median":-8.433714,"eighty":-7.765889,"marketCap":268778316},{"date":"2025-10-31","current":-6.313457,"twenty":-9.483717,"median":-8.407597,"eighty":-7.712692,"marketCap":240075500},{"date":"2025-11-07","current":-32.123937,"twenty":-9.483717,"median":-8.357187,"eighty":-7.629646,"marketCap":226281012},{"date":"2025-11-14","current":-40.859748,"twenty":-9.612136,"median":-8.426787,"eighty":-7.645096,"marketCap":287816063},{"date":"2025-11-21","current":-39.033478,"twenty":-9.689255,"median":-8.436208,"eighty":-7.6834,"marketCap":274951817},{"date":"2025-11-28","current":-41.298053,"twenty":-9.979319,"median":-8.479321,"eighty":-7.706834,"marketCap":290903482},{"date":"2025-12-05","current":-41.273702,"twenty":-10.143173,"median":-8.502923,"eighty":-7.743335,"marketCap":290731959}],"updateTime":1765179241315},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNWV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589334455","title":"SANUWAVE Health Adds UltraMIST to Healogics iSupply GPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2589334455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589334455?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:00","pubTimestamp":1765191612,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. announced that its UltraMIST product line has been added to Healogics iSupply, the Group Purchasing Organization  of Healogics Wound Care Supply. This collaboration will make UltraMIST available as an option for iSupply members, which include Wound Care Centers, home health agencies, and skilled nursing facilities. SANUWAVE plans to roll out the UltraMIST system to initial Healogics iSupply member locations by the end of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLwPxkX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4585","BK4588","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SNWV","BK4112","SG9999014021.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2581836302","title":"Analysts’ Top Healthcare Picks: Rapid Micro Biosystems (RPID), Sanuwave Health (SNWV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581836302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581836302?lang=en_us&edition=fundamental","pubTime":"2025-11-08 03:30","pubTimestamp":1762543829,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rapid Micro Biosystems (RPID – Research Report) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-rapid-micro-biosystems-rpid-sanuwave-health-snwv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-rapid-micro-biosystems-rpid-sanuwave-health-snwv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","RPID","BK4539","LABU","XLV","HCSG","LU0029874061.USD","BK4585","BK4588","BK4581","BK4121","XBI","BK4082","SNWV"],"gpt_icon":0},{"id":"2581009072","title":"Sanuwave Health Inc - Q3 2025 Revenues up 22% to $11.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009072?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA8NH4L0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2581009070","title":"Sanuwave Health Inc - Q4 2025 Revenue Guidance $13-$14 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009070?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA8NH4L0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2581004468","title":"Sanuwave Announces Q3 FY2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581004468","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581004468?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513200,"startTime":"0","endTime":"0","summary":"Q3 2025 revenues were$11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024.  GA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183487/20998/en/Sanuwave-Announces-Q3-FY2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2581045704","title":"SANUWAVE Health Q3 EPS $0.46 Beats $0.32 Estimate, Sales $11.451M Beat $11.430M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045704","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045704?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:58","pubTimestamp":1762466326,"startTime":"0","endTime":"0","summary":"SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.32 by 43.75 percent. This is a 107.09 percent increase over losses of $(6.49) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48706114/sanuwave-health-q3-eps-0-46-beats-0-32-estimate-sales-11-451m-beat-11-430m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SANUWAVE Health Q3 EPS $0.46 Beats $0.32 Estimate, Sales $11.451M Beat $11.430M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2580742758","title":"SANUWAVE Health Inc  expected to post earnings of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580742758","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580742758?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:38","pubTimestamp":1762267098,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc  expected to post earnings of32cents a share - Earnings Preview SANUWAVE Health Inc SNWV.OQ SNWV.O is expected to  report resultson November 7 for the period ending September 30 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG233:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2580225004","title":"Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2580225004","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580225004?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:35","pubTimestamp":1762205700,"startTime":"0","endTime":"0","summary":"EDEN PRAIRIE, Minn., Nov.  03, 2025  (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the \"Company\" or \"Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, wil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179863/20998/en/Sanuwave-Will-Host-a-Conference-Call-on-November-7-2025-at-8-30-AM-ET-to-Present-Q3-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4581","AM","BK4588","ET","IE00BZ18W456.USD","IE00BMQBXF63.USD","BK4181","BK4590","IE00BZ18W340.USD","BK4561","BK4144","BK4218","BK4585","SNWV","HST"],"gpt_icon":0},{"id":"2580291818","title":"BRIEF-Sanuwave Health Says 2026 Reimbursement For 97610 Code For Ultramist Products Is Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2580291818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580291818?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:00","pubTimestamp":1762167653,"startTime":"0","endTime":"0","summary":"BRIEF-Sanuwave Health Says 2026 Reimbursement For 97610 Code For Ultramist Products Is Unchanged Nov 3 (Reuters) - Sanuwave Health Inc SNWV.O:SANUWAVE HEALTH INC - REIMBURSEMENT FOR 97610 CODE FOR ULT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WE04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2580295917","title":"Sanuwave Health Inc - Reimbursement for 97610 Code for Ultramist Products Remains Unchanged for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2580295917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580295917?lang=en_us&edition=fundamental","pubTime":"2025-11-03 18:08","pubTimestamp":1762164521,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WE04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2580529518","title":"CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580529518","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580529518?lang=en_us&edition=fundamental","pubTime":"2025-11-03 18:00","pubTimestamp":1762164000,"startTime":"0","endTime":"0","summary":"CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 97610 2026 rates for physician offices, home visits, long-term care, and hospitals are in line with the pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3178949/20998/en/CMS-Publishes-Final-Rule-for-Calendar-Year-2026-Physician-Fee-Schedule-for-UltraMIST-Procedure-CPT-code-97610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2500361329.USD","LU2346227817.USD","BK4585","LU1003077747.HKD","LU1894683348.USD","BK4215","BK4588","LU0545039389.USD","SNWV","CPT","LU2637428348.USD","LU1894683264.USD","BK4082","LU0738911758.USD","LU0661504455.SGD","LU0949170772.SGD","CMS","BK4208","LU0553294199.USD"],"gpt_icon":0},{"id":"2574118962","title":"Opaleye Management Inc. Reports Acquisition of SANUWAVE Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2574118962","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574118962?lang=en_us&edition=fundamental","pubTime":"2025-10-10 07:10","pubTimestamp":1760051435,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. has reported the acquisition of common shares of SANUWAVE Health Inc. as a beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL1bk1s1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2573329952","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2573329952","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573329952?lang=en_us&edition=fundamental","pubTime":"2025-10-07 19:49","pubTimestamp":1759837744,"startTime":"0","endTime":"0","summary":"Society Pass  shares were 24% lower pre-bell Tuesday, paring Monday's rally.Aehr Test Systems  stock was down 21% after the company reported late Monday lower fiscal Q1 non-GAAP earnings and revenue.Sanuwave Health  shares were 16% lower, a day after the company reported preliminary Q3 revenue that trailed its previous guidance.Aether  stock was down 16% after a 3.2% loss in the previous session.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4147","BK4112","AEHR","SOPA","ATHR","BK4563","BK4585","BK4588","BK4077","BK4082","SNWV"],"gpt_icon":0},{"id":"2573993564","title":"Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573993564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573993564?lang=en_us&edition=fundamental","pubTime":"2025-10-07 10:55","pubTimestamp":1759805705,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kyle Bauser from Roth MKM reiterated a Buy rating on Sanuwave Health, with a price target of $53.00. The company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-sanuwave-health-snwv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-sanuwave-health-snwv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNWV"],"gpt_icon":0},{"id":"2573857279","title":"SANUWAVE Health Inc. Files Initial Statement of Beneficial Ownership for Chief Operating Officer Daniel Coyle","url":"https://stock-news.laohu8.com/highlight/detail?id=2573857279","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573857279?lang=en_us&edition=fundamental","pubTime":"2025-10-07 05:10","pubTimestamp":1759785026,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Daniel Coyle as the beneficial owner, serving in the role of Chief Operating Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL8VvbPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2573985561","title":"Sanuwave Shares Plunge After Revenue Guidance Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2573985561","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573985561?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:52","pubTimestamp":1759783920,"startTime":"0","endTime":"0","summary":"Sanuwave Health said it expects third-quarter revenue of $11.4 million to $11.6 million, below its previous expectations, blaming uncertainty around proposed reimbursement changes for some treatment modalities.Its stock dropped 20.4% to $32.50 in after-hours trading on Monday.The company, which develops patented noninvasive, biological response activating devices, previously expected revenue between $12 million and $12.7 million for its three-month period ended Sept. 30.The uncertainty affected purchase decisions, which were delayed and patient counts were reduced as providers took a wait-and-see approach to potential changes, CEO Morgan Frank said. \"This made for a difficult environment,\" he added.As a result, Sanuwave said it cut its revenue forecast for fiscal 2025 to between $44 million to $46 million from previous guidance of $48 million to $50 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sanuwave Shares Plunge After Revenue Guidance Cut","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2573631988","title":"Sanuwave Health Inc - 2025 Annual Revenue Guidance Altered to $44-$46 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2573631988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573631988?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:01","pubTimestamp":1759780860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUASVHK9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2573666988","title":"Press Release: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573666988","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573666988?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:01","pubTimestamp":1759780860,"startTime":"0","endTime":"0","summary":"Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history.Q3 2025 revenue increased between 22% and 24% vs Q3 2024 and between 12% and 14% sequentially vs the prior quarter. First nine months of 2025 revenue increased 39-40% vs first nine months of 2024.As many have asked, UltraMIST reimbursement is not affected by the potential changes in allograft reimbursement and, while it is not yet final, based upon the guidance we have seen so far, we expect reimbursement for the 97610 code to increase very slightly in 2026 as compared to 2025. While the current disruption has been a near-term challenge, we suspect it represents a significant future opportunity, and we continue to feel good about our pipeline and our progress.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2572568574","title":"SANUWAVE Health Appoints Daniel Coyle as COO, Terminates President Andrew Walko in Leadership Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2572568574","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572568574?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:14","pubTimestamp":1759353259,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has appointed Daniel Coyle as Chief Operating Officer, effective September 25, 2025. Coyle previously served as the company's Vice President of Engineering and Operations. Peter Stegagno, the former Chief Operating Officer, has been reassigned as Chief Regulatory Officer. Additionally, President Andrew Walko has been terminated without cause, effective October 24, 2025, and the company does not plan to appoint a new President at this time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 01, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL37Ppch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2571871878","title":"Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571871878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571871878?lang=en_us&edition=fundamental","pubTime":"2025-09-29 09:35","pubTimestamp":1759109704,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Kyle Bauser reiterated a Buy rating on Sanuwave Health on September 26 and set a price target of $55.00. The company’s shares clos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-sanuwave-health-snwv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-sanuwave-health-snwv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNWV"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}